# FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD)

> **NCT01676324** · — · COMPLETED · sponsor: **University of British Columbia** · enrollment: 289 (actual)

## Conditions studied

- Inflammatory Bowel Disease
- Crohn's Disease
- Ulcerative Colitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01676324
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-03
- **Final completion:** 2013-09
- **Target enrollment:** 289 (ACTUAL)
- **Last updated:** 2014-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01676324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01676324, "FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01676324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*